During the past decade, The Alfred Hospital Malignant Haematology & Stem Cell Transplantation Services conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "The Alfred Hospital Malignant Haematology & Stem Cell Transplantation Services" #1 collaborator was "ADIR, a Servier Group company" with 2 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "The Alfred Hospital Malignant Haematology & Stem Cell Transplantation Services" are "Acute Myeloid Leukaemia" (1 trials), "B-Cell Non-Hodgkin Lymphoma (NHL)" (1 trials), "Chronic Lymphocytic Leukaemia (CLL)" (1 trials), "Multiple Myeloma" (1 trials) and "Multiple Myeloma (MM)" (1 trials). Many other conditions were trialed in "The Alfred Hospital Malignant Haematology & Stem Cell Transplantation Services" in a lesser frequency.

Most popular intervention types in "The Alfred Hospital Malignant Haematology & Stem Cell Transplantation Services" are "Drug" (4 trials). Other intervention types were less common.

The name of intervention was led by "CC-5013" (1 trials), "S 55746" (1 trials), "S 64315 (also referred as MIK665) and azacitidine" (1 trials) and "pomalidomide" (1 trials). Other intervention names were less common.

The vast majority of trials in "The Alfred Hospital Malignant Haematology & Stem Cell Transplantation Services" are 4 trials for "All" genders.

Currently, there are NaN active trials in "The Alfred Hospital Malignant Haematology & Stem Cell Transplantation Services". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in The Alfred Hospital Malignant Haematology & Stem Cell Transplantation Services, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in The Alfred Hospital Malignant Haematology & Stem Cell Transplantation Services, 2 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".